glp-1 receptor agonist atrial fibrillation risk HRS 2026 Insights: Glucagon-Like Peptide-1 Agonists Reduce Independently of Effects on Weight Loss and Survival Frontiers | GLP-1 Receptor Agonists:
Description
Glucagon-like peptide-1 receptor agonists for non-alcoholic fatty liver disease in type 2 diabetes: A meta-analysis
10.1111/bph.15059 73 ZhangL.LiC.ZhangZ.ZhangZ.JinQ
Tinsley GM, Heymsfield SB
People of color have higher obesity rates in the U.S
Neuroprotection of Exendin-4 by enhanced autophagy in a Parkinsonian Rat Model of alpha-Synucleinopathy
